Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Endo, Y.; Yamashita, H.; Takahashi, S.; Sato, S.; Yoshimoto, N.; Asano, T.; Hato, Y.; Dong, Y.; Fujii, Y.; Toyama, T.
    Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer (2015), BMC Cancer, 14, 990.
    View publication on PubMedView publication on EuropePMC

Application

EC Number Application Comment Organism
2.3.1.5 medicine enzyme expression is correlated with improved overall survival of breast cancer patients. The enzyme is a possible prognostic biomarker for lymph node-positive breast cancer Homo sapiens

Inhibitors

EC Number Inhibitors Comment Organism Structure
2.3.1.5 tamoxifen
-
 Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
2.3.1.5 Homo sapiens
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
2.3.1.5 breast cancer cell
-
 Homo sapiens
-

Synonyms

EC Number Synonyms Comment Organism
2.3.1.5 arylamine N-acetyltransferase 1
-
 Homo sapiens
2.3.1.5 NAT1
-
 Homo sapiens